
IndraLab
Statements
reach
"These data suggest that EGF-mediated p-ERK induction in NF1-null cells is not dependent on SOS1 activity.To determine the relative sensitivity of these different melanoma genotypes to MAPK pathway inhibition, we used three allosteric MEK inhibitors with distinct biochemical properties.12 13 The first, trametinib, promotes the dissociation of RAF-MEK1/2 complexes, antagonizing MEK1 and MEK2 phosphorylation at serine 218."
reach
"The strong activation of p-ERK by EGF at both 10 and 30 min post-stimulation results in the p-ERK coefficients projecting towards the EGF scores (compare in Fig. 1C and 1D), while the strong activation of the p38 pathway by IL-1α and TNFα results in the p-p38 coefficients projecting towards the IL-1α and TNFα scores (compare in Fig. 1C and 1D)."
sparser
"The strong activation of p-ERK by EGF at both 10 and 30 min post-stimulation results in the p-ERK coefficients projecting towards the EGF scores (compare in xref ), while the strong activation of the p38 pathway by IL-1α and TNFα results in the p-p38 coefficients projecting towards the IL-1α and TNFα scores (compare in xref )."
reach
"The activation of human epidermal growth factor receptor-2 (HER2) results in the activation of the mitogen activated protein kinase (MAPK) cascade that may lead to the resistance to anti-estrogen therapy in estrogen receptor (ERalpha) expressing breast cancer by means of phosphorylation of ERalpha in the N-terminal region by phosphorylated extracellular signal regulated kinase 1/2 (pERK1/2) and by means of decreasing ERalpha expression."